1-13 of 13
Allison Barraclough
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biological Features of Response to Immune Checkpoint Inhibitor and Rituximab Priming in Diffuse Large B-Cell Lymphoma

Rakin Chowdhury, Kate Manos, Melinda Burgess, Geoffrey Chong, Sze-Ting Lee, Zachary Hawula, Nella Tuczko, Charmaine Smith, Tineke Fancourt, Leonid Churilov, Andrew Scott, Allison Barraclough, Joel Wight, Joe McKendrick, Wendi Lin, Fiona Swain, Eliza A. Hawkes, Colm Keane
Journal: Blood
Blood (2024) 144 (Supplement 1): 6213.
https://doi.org/10.1182/blood-2024-201230
Published: 2024
Journal Articles

Follicular Lymphoma Displays Distinct Gene Expression Profiles According to Histological Grade

Allison Barraclough, Eliza A. Hawkes, Denise Lee, James Nguyen, Patrick Hosking, Wendi Lin, Shivam Agrawal, Kimberly Wong, Geoffrey Chong, Enid Lam
Journal: Blood
Blood (2024) 144 (Supplement 1): 6203.
https://doi.org/10.1182/blood-2024-206571
Published: 2024
Journal Articles

T Cell CD62L Expression Following Nivolumab Therapy Is Associated with Long Term Response to Rituximab-Nivolumab in Treatment Naïve Follicular Lymphoma: Results from the 1 st FLOR Study

Rachel Koldej, Allison Barraclough, Sze Ting Lee, Huw Morgan, Nicholas Holzwart, Minu Koshy, Charmaine Smith, Geoffrey Chong, Michael Gilbertson, Colm Keane, Denise Lee, Leonid Churilov, David S. Ritchie, Eliza A. Hawkes
Journal: Blood
Blood (2024) 144 (Supplement 1): 4376.
https://doi.org/10.1182/blood-2024-199854
Published: 2024
Journal Articles

Tribulations of trials in aggressive lymphoma

Clinical Trials & Observations
Allison Barraclough, Eliza A. Hawkes
Journal: Blood
Blood (2023) 142 (26): 2232–2234.
https://doi.org/10.1182/blood.2023022382
Published: 2023
Journal Articles

Limited-stage diffuse large B-cell lymphoma

Eliza A. Hawkes, Allison Barraclough, Laurie H. Sehn
Journal: Blood
Blood (2022) 139 (6): 822–834.
https://doi.org/10.1182/blood.2021013998
Published: 2022
Journal Articles

A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm Trial

Eliza Hawkes, Shivam Agrawal, Sze-Ting Lee, Joel Wight, Greg Hapgood, Tasman Armytage, Nicole Wong Doo, Tara Cochrane, Chan-Yoon Cheah, Ian Bilmon, Matthew Ku, Stephen Opat, Bianca Devitt, Chun Yew Fong, Tineke Fancourt, Mannu Walia, Gloria Nkhoma, Allison Barraclough
Journal: Blood
Blood (2021) 138 (Supplement 1): 4516.
https://doi.org/10.1182/blood-2021-149308
Published: 2021
Journal Articles

Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance

Stephen Boyle, MBChB, BSc(Hons), MRCP(UK), Joshua W.D. Tobin, MD, Jacinta Perram, MBBS,BSc,MPH,BA, Nada Hamad, MBBS,BSc,MSc,FRACP FRCPA, Allison Barraclough, MBBS FRACP FRCPA, Lydia Singaraveloo, Min-Hi Han, MBBS, BSc, Richard Blennerhassett, Niles Elizabeth Nelson, BSc, MBBS, Anna Johnston, MBBS (Hons 1), FRACP, FRCPA, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Krishna Karpe, Abir Bhattacharyya, MBBS, FRACP, FRCPA, Chan Yoon Cheah, MBBS, Elango Subramoniapillai, MBBS, FRACP, Waqas Bokhari, Cindy Lee, MD, Eliza A Hawkes, FRACP,MDMBBS, Veena Gullapalli, MBBS FRACP FRCPA, Andrew Jabbour, Simone Strasser, MBBS MDFRACP FAASLD, Steve Chadban, BMed(hons), PhD FRACP, FAHMS, Christina Brown, MBBS PhDFRACP FRCPA, Peter Mollee, FRACP,MBBS,MSc,FRCPA, Greg Hapgood, BMBS, FRACP, FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
https://doi.org/10.1182/blood-2020-140665
Published: 2020
Journal Articles

Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study

Eliza A Hawkes, FRACP,MDMBBS, Geoffrey Chong, MD, Charmaine Smith, Sze-Ting Lee, Leonid Churilov, Joseph McKendrick, William Renwick, Piers Blombery, MBBS, Niles Elizabeth Nelson, BSc, MBBS, Tineke Fancourt, Joanne Hawking, Wendi Lin, Andrew M Scott, Allison Barraclough, Joel Wight, Andrew Grigg, MBBS, MD FRACP, FRCPA, Colm Keane, MD, Chun Yew Fong, MBBS, PhD FRACP, FRCPA, Kate Manos, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-136024
Published: 2020
Journal Articles

The 'Real World' Uptake and Prognostic Impact of GELF in Newly Diagnosed Follicular Lymphoma: An Australasian Alliance Initiative

Allison Barraclough, Edward Yoo, Chan Y. Cheah, Dipti Talaulikar, Bianca Nguyen, Michelle Turner, Fatima Tahir, Jing Huang, Colm Keane, MD, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, MBBS,FRACP,FRCPA, Stephen Opat, Zoe McQuilten, Erica M. Wood, Gayathri St George, Cameron Wellard, Eliza A Hawkes
Journal: Blood
Blood (2019) 134 (Supplement_1): 3986.
https://doi.org/10.1182/blood-2019-129294
Published: 2019
Journal Articles

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study

Eliza A Hawkes, Kate Manos, Geoff Chong, Jodie Palmer, Michael MacManus, Colm Keane, MD, Andrew Scott, Jake Shortt, MBBS FRACP FRCPA PhD, David Ritchie, MD PhD, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze-Ting Lee, Wendi Lin, Rachel Koldej, Richard Khor
Journal: Blood
Blood (2019) 134 (Supplement_1): 5328.
https://doi.org/10.1182/blood-2019-122635
Published: 2019
Journal Articles

AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Eliza A Hawkes, Kate Manos, MBBS, Charmaine Smith, Joanne Hawking, Stephanie O'Brien, Leonid Churilov, Joseph McKendrick, William Renwick, Andrew Grigg, Tom Witkowski, Andrew Scott, Sze-Ting Lee, Wendi Lin, Chun Fong, Carmela Rooney, Allison Barraclough, Joel Wight, Geoff Chong
Journal: Blood
Blood (2019) 134 (Supplement_1): 5332.
https://doi.org/10.1182/blood-2019-127858
Published: 2019
Journal Articles

Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1 st FLOR' Study

Allison Barraclough, Geoff Chong, Michael Gilbertson, Andrew Grigg, Leonid Churilov, Tineke Fancourt, David Ritchie, MD PhD, Rachel Koldej, Rishu Agarwal, Kate Manos, Charmaine Smith, Kristen Houdyk, Joanne Hawking, Eliza Hawkes
Journal: Blood
Blood (2019) 134 (Supplement_1): 1523.
https://doi.org/10.1182/blood-2019-123908
Published: 2019
Journal Articles

Impact of Immunohistochemistry-Defined Cell of Origin and MYC Rearrangements on Outcomes in Patients with PET-Defined Stage I/II Diffuse Large B-Cell Lymphoma Treated with R-CHOP ± Radiotherapy: An International Multi-Center Retrospective Study

Allison Barraclough, MBBS, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris Van Vliet, Laurie H. Sehn, MDMPH, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Pedro Farinha, Jorne Lionel Biccler, MSc, Joseph M Connors, MD, David W. Scott, MD PhD FRACP, FRCPA, Kerry J Savage, MD, Tarec Christoffer El-Galaly, MD PhD, Diego Villa, MD, Chan Yoon Cheah
Journal: Blood
Blood (2017) 130 (Supplement 1): 415.
https://doi.org/10.1182/blood.V130.Suppl_1.415.415
Published: 2017